Successful use of etoposide for pyoderma gangrenosum associated with myelodysplastic syndrome and trisomy 8: cytokine profiles during treatment

Eur J Dermatol. 2017 Oct 1;27(5):525-527. doi: 10.1684/ejd.2017.3067.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • C-Reactive Protein / analysis
  • Chromosomes, Human, Pair 8
  • Etoposide / therapeutic use*
  • Female
  • Granulocyte Colony-Stimulating Factor / blood
  • Humans
  • Interleukin-8 / blood
  • Middle Aged
  • Myelodysplastic Syndromes / blood
  • Myelodysplastic Syndromes / complications*
  • Myelodysplastic Syndromes / drug therapy
  • Prothrombin Time
  • Pyoderma Gangrenosum / blood
  • Pyoderma Gangrenosum / complications*
  • Pyoderma Gangrenosum / drug therapy
  • Trisomy*

Substances

  • Antineoplastic Agents, Phytogenic
  • Interleukin-8
  • Granulocyte Colony-Stimulating Factor
  • Etoposide
  • C-Reactive Protein

Supplementary concepts

  • Chromosome 8, trisomy